4.6 Article

Computer-Aided Diagnosis of Parkinson's Disease Using Enhanced Probabilistic Neural Network

期刊

JOURNAL OF MEDICAL SYSTEMS
卷 39, 期 11, 页码 -

出版社

SPRINGER
DOI: 10.1007/s10916-015-0353-9

关键词

Computer-aided diagnosis; Parkinson's disease; Enhanced probabilistic neural networks

资金

  1. Michael J. Fox Foundation for Parkinson's Research
  2. AbbVie
  3. Avid
  4. Biogen
  5. Bristol-Myers Squibb
  6. Covance
  7. GE Healthcare
  8. Genentech
  9. GlaxoSmithKline
  10. Eli Lilly and Company
  11. Lundbeck
  12. Merck
  13. Meso Scale Discovery
  14. Pfizer
  15. Piramal Imaging
  16. Roche
  17. Servier
  18. UCB

向作者/读者索取更多资源

Early and accurate diagnosis of Parkinson's disease (PD) remains challenging. Neuropathological studies using brain bank specimens have estimated that a large percentages of clinical diagnoses of PD may be incorrect especially in the early stages. In this paper, a comprehensive computer model is presented for the diagnosis of PD based on motor, non-motor, and neuroimaging features using the recently-developed enhanced probabilistic neural network (EPNN). The model is tested for differentiating PD patients from those with scans without evidence of dopaminergic deficit (SWEDDs) using the Parkinson's Progression Markers Initiative (PPMI) database, an observational, multi-center study designed to identify PD biomarkers for diagnosis and disease progression. The results are compared to four other commonly-used machine learning algorithms: the probabilistic neural network (PNN), support vector machine (SVM), k-nearest neighbors (k-NN) algorithm, and classification tree (CT). The EPNN had the highest classification accuracy at 92.5 % followed by the PNN (91.6 %), k-NN (90.8 %) and CT (90.2 %). The EPNN exhibited an accuracy of 98.6 % when classifying healthy control (HC) versus PD, higher than any previous studies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据